CASI vs. KLAC
Compare and contrast key facts about CASI Pharmaceuticals, Inc. (CASI) and KLA Corporation (KLAC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CASI or KLAC.
Correlation
The correlation between CASI and KLAC is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CASI vs. KLAC - Performance Comparison
Key characteristics
CASI:
-0.57
KLAC:
0.40
CASI:
-0.61
KLAC:
0.78
CASI:
0.93
KLAC:
1.11
CASI:
-0.58
KLAC:
0.55
CASI:
-1.41
KLAC:
1.08
CASI:
41.16%
KLAC:
15.73%
CASI:
103.06%
KLAC:
42.96%
CASI:
-99.99%
KLAC:
-83.74%
CASI:
-99.98%
KLAC:
-14.64%
Fundamentals
CASI:
$86.58M
KLAC:
$100.76B
CASI:
-$2.03
KLAC:
$23.72
CASI:
0.00
KLAC:
1.48
CASI:
$15.18M
KLAC:
$10.84B
CASI:
$7.92M
KLAC:
$6.53B
CASI:
-$28.55M
KLAC:
$4.52B
Returns By Period
In the year-to-date period, CASI achieves a -10.78% return, which is significantly lower than KLAC's 20.33% return. Over the past 10 years, CASI has underperformed KLAC with an annualized return of -17.16%, while KLAC has yielded a comparatively higher 30.47% annualized return.
CASI
-10.78%
-3.63%
-60.39%
-56.47%
-34.52%
-17.16%
KLAC
20.33%
0.10%
-6.31%
15.41%
37.05%
30.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CASI vs. KLAC — Risk-Adjusted Performance Rank
CASI
KLAC
CASI vs. KLAC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for CASI Pharmaceuticals, Inc. (CASI) and KLA Corporation (KLAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CASI vs. KLAC - Dividend Comparison
CASI has not paid dividends to shareholders, while KLAC's dividend yield for the trailing twelve months is around 0.61%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CASI CASI Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KLAC KLA Corporation | 0.61% | 0.96% | 0.92% | 1.25% | 0.91% | 1.35% | 1.74% | 3.17% | 2.15% | 2.67% | 2.94% | 26.17% |
Drawdowns
CASI vs. KLAC - Drawdown Comparison
The maximum CASI drawdown since its inception was -99.99%, which is greater than KLAC's maximum drawdown of -83.74%. Use the drawdown chart below to compare losses from any high point for CASI and KLAC. For additional features, visit the drawdowns tool.
Volatility
CASI vs. KLAC - Volatility Comparison
CASI Pharmaceuticals, Inc. (CASI) has a higher volatility of 18.84% compared to KLA Corporation (KLAC) at 9.47%. This indicates that CASI's price experiences larger fluctuations and is considered to be riskier than KLAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CASI vs. KLAC - Financials Comparison
This section allows you to compare key financial metrics between CASI Pharmaceuticals, Inc. and KLA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities